Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

Pamela Kearns; Christian M Zwaan; Dirk Reinhardt; Brenda Gibson; Lucas Moreno; Karsten Nysom; Susumu Nakahara; Fei Huang; Wangda Zhou; Dolly A Parasrampuria; Sepideh Nemat

doi:10.1111/bjh.15847

Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

Pamela Kearns, Christian M Zwaan, Dirk Reinhardt, Brenda Gibson, Lucas Moreno, Karsten Nysom, Susumu Nakahara, Fei Huang, Wangda Zhou, Dolly A Parasrampuria, Sepideh Nemat

Afdeling for Børn og Unge JMC

5 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	British Journal of Haematology
Vol/bind	186
Udgave nummer	3
Sider (fra-til)	e7-e11
ISSN	0007-1048
DOI	https://doi.org/10.1111/bjh.15847
Status	Udgivet - 2019

Adgang til dokumentet

10.1111/bjh.15847

Citationsformater

Kearns, P., Zwaan, C. M., Reinhardt, D., Gibson, B., Moreno, L., Nysom, K., Nakahara, S., Huang, F., Zhou, W., Parasrampuria, D. A., & Nemat, S. (2019). Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia. British Journal of Haematology, 186(3), e7-e11. https://doi.org/10.1111/bjh.15847

Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia. / Kearns, Pamela; Zwaan, Christian M; Reinhardt, Dirk et al.
I: British Journal of Haematology, Bind 186, Nr. 3, 2019, s. e7-e11.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Kearns, P, Zwaan, CM, Reinhardt, D, Gibson, B, Moreno, L, Nysom, K, Nakahara, S, Huang, F, Zhou, W, Parasrampuria, DA & Nemat, S 2019, 'Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia', British Journal of Haematology, bind 186, nr. 3, s. e7-e11. https://doi.org/10.1111/bjh.15847

@article{c9933977929a43c4bcbf084ac5dea65b,

title = "Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia",

author = "Pamela Kearns and Zwaan, {Christian M} and Dirk Reinhardt and Brenda Gibson and Lucas Moreno and Karsten Nysom and Susumu Nakahara and Fei Huang and Wangda Zhou and Parasrampuria, {Dolly A} and Sepideh Nemat",

year = "2019",

doi = "10.1111/bjh.15847",

language = "English",

volume = "186",

pages = "e7--e11",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

AU - Kearns, Pamela

AU - Zwaan, Christian M

AU - Reinhardt, Dirk

AU - Gibson, Brenda

AU - Moreno, Lucas

AU - Nysom, Karsten

AU - Nakahara, Susumu

AU - Huang, Fei

AU - Zhou, Wangda

AU - Parasrampuria, Dolly A

AU - Nemat, Sepideh

PY - 2019

Y1 - 2019

U2 - 10.1111/bjh.15847

DO - 10.1111/bjh.15847

M3 - Journal article

C2 - 30847896

SN - 0007-1048

VL - 186

SP - e7-e11

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 3

ER -